Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	100.00	58.51	0.00
Graham Fair Price	41.42	70.87	50.11
PEG	-53.98	0.15	-0.32
Price/Book	6.95	0.79	0.74
Price/Cash Flow	99.84	-296.85	-185602.15
Prices/Earnings	-46.53	14.63	27.35
Price/Sales	30189.85	-33082.75	109.22
Price/FCF	99.84	-296.85	-185602.15
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	28222.22	-283.22	1.00
Operating Margin	56544.44	-565.44	1.00
ROA	100.00	0.01	< 0.005
ROE	< 0.005	0.01	100.00
ROIC	< 0.005	< 0.005	-0.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.86	1.00	16.17
EPS QOQ	-0.86	1.00	16.20
FCF QOQ	-1.00	-667.67	-66638.69
Revenue QOQ	-0.11	-1.00	-809.85
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.00	0.00
Quick Ratio	0.01	0.01	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	128.55	128.55	< 0.005
Cash	< 0.005	< 0.005	< 0.005
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	-0.34	-66766.70
Revenue	0.87	< 0.005	-99.65
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.19	0.19	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.00	< 0.005	-100.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating